- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 13.45M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $87.37M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $43.3M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $28.37M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $220.74M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $236.37M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $81.15M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $92.65M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $203.01M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $168.07M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $134.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $110.45M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $405.07M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $513.07M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 14.66M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $3.21M |
| Capex | Q1 2025 · Mar 31, 2024 | $5.61M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $5.99M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.35 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.35 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $18.64M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$5.13M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.78M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $35.68M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $130.45M |
| Revenue | Q1 2025 · Mar 31, 2024 | $166.12M |